Cargando…

Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms

Clear cell renal cell carcinoma (CCRCC) is the most common origin for metastasis in the thyroid. A 51-year-old woman was referred to our hospital for a subcarinal lesion. Ten years before, the patient had undergone a nephrectomy for CCRCC. Whole-body fluorodeoxyglucose positron emission tomography r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamarrón, Carlos, Abdulkader, Ihab, Areses, María C., García-Paz, Vanesa, León, Luís, Cameselle-Teijeiro, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639688/
https://www.ncbi.nlm.nih.gov/pubmed/23878753
http://dx.doi.org/10.1155/2013/485025
_version_ 1782475980247400448
author Zamarrón, Carlos
Abdulkader, Ihab
Areses, María C.
García-Paz, Vanesa
León, Luís
Cameselle-Teijeiro, José
author_facet Zamarrón, Carlos
Abdulkader, Ihab
Areses, María C.
García-Paz, Vanesa
León, Luís
Cameselle-Teijeiro, José
author_sort Zamarrón, Carlos
collection PubMed
description Clear cell renal cell carcinoma (CCRCC) is the most common origin for metastasis in the thyroid. A 51-year-old woman was referred to our hospital for a subcarinal lesion. Ten years before, the patient had undergone a nephrectomy for CCRCC. Whole-body fluorodeoxyglucose positron emission tomography revealed elevated values in the thyroid gland, while the mediastinum was normal. An endoscopic ultrasonography-guided fine-needle aspiration biopsy of the mediastinal mass was consistent with CCRCC, and this was confirmed after resection. The thyroidectomy specimen also revealed lymphocytic thyroiditis, nodular hyperplasia, one follicular adenoma, two papillary microcarcinomas, and six foci of metastatic CCRCC involving both thyroid lobes. Curiously two of the six metastatic foci were located inside two adenomatoid nodules (tumor-in-tumor). The metastatic cells were positive for cytokeratins, CD10, epidermal growth factor receptor, and vascular endothelial growth factor receptor 2. No BRAF gene mutations were found in any of the primary and metastatic lesions. The patient was treated with sunitinib and finally died due to CCRCC distant metastases 6 years after the thyroidectomy. In CCRCC patients, a particularly prolonged survival rate may be achieved with the appropriate therapy, in contrast to the ominous prognosis typically found in patients with thyroid metastases from other origins.
format Online
Article
Text
id pubmed-3639688
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36396882013-07-22 Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms Zamarrón, Carlos Abdulkader, Ihab Areses, María C. García-Paz, Vanesa León, Luís Cameselle-Teijeiro, José Case Rep Oncol Med Case Report Clear cell renal cell carcinoma (CCRCC) is the most common origin for metastasis in the thyroid. A 51-year-old woman was referred to our hospital for a subcarinal lesion. Ten years before, the patient had undergone a nephrectomy for CCRCC. Whole-body fluorodeoxyglucose positron emission tomography revealed elevated values in the thyroid gland, while the mediastinum was normal. An endoscopic ultrasonography-guided fine-needle aspiration biopsy of the mediastinal mass was consistent with CCRCC, and this was confirmed after resection. The thyroidectomy specimen also revealed lymphocytic thyroiditis, nodular hyperplasia, one follicular adenoma, two papillary microcarcinomas, and six foci of metastatic CCRCC involving both thyroid lobes. Curiously two of the six metastatic foci were located inside two adenomatoid nodules (tumor-in-tumor). The metastatic cells were positive for cytokeratins, CD10, epidermal growth factor receptor, and vascular endothelial growth factor receptor 2. No BRAF gene mutations were found in any of the primary and metastatic lesions. The patient was treated with sunitinib and finally died due to CCRCC distant metastases 6 years after the thyroidectomy. In CCRCC patients, a particularly prolonged survival rate may be achieved with the appropriate therapy, in contrast to the ominous prognosis typically found in patients with thyroid metastases from other origins. Hindawi Publishing Corporation 2013 2013-04-11 /pmc/articles/PMC3639688/ /pubmed/23878753 http://dx.doi.org/10.1155/2013/485025 Text en Copyright © 2013 Carlos Zamarrón et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Zamarrón, Carlos
Abdulkader, Ihab
Areses, María C.
García-Paz, Vanesa
León, Luís
Cameselle-Teijeiro, José
Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms
title Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms
title_full Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms
title_fullStr Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms
title_full_unstemmed Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms
title_short Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms
title_sort metastases of renal cell carcinoma to the thyroid gland with synchronous benign and malignant follicular cell-derived neoplasms
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639688/
https://www.ncbi.nlm.nih.gov/pubmed/23878753
http://dx.doi.org/10.1155/2013/485025
work_keys_str_mv AT zamarroncarlos metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms
AT abdulkaderihab metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms
AT aresesmariac metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms
AT garciapazvanesa metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms
AT leonluis metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms
AT cameselleteijeirojose metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms